{"id":51643,"date":"2023-01-06T12:30:01","date_gmt":"2023-01-06T07:00:01","guid":{"rendered":"https:\/\/corpbiz.io\/learning\/?p=51643"},"modified":"2023-04-10T17:39:01","modified_gmt":"2023-04-10T12:09:01","slug":"cdsco-registration-for-obstetrical-and-gynaecological-medical-devices","status":"publish","type":"post","link":"https:\/\/corpbiz.io\/learning\/cdsco-registration-for-obstetrical-and-gynaecological-medical-devices\/","title":{"rendered":"CDSCO Registration for Obstetrical and Gynaecological Medical Devices"},"content":{"rendered":"\n

The field of medicine known as obstetrics and gynaecology is dedicated\nto the care of women during pregnancy and childbirth, as well as the diagnosis\nand treatment of conditions affecting the female reproductive system. It also\nfocuses on various conditions affecting the health of women, including\ninfertility, menopause, and hormonal difficulties. It also goes by the name\nOB-GYN. The Central Drugs Standard Control Organization, also called CDSCO, is\na regulatory organisation for the Indian medical device industry under the Drugs and\nCosmetics Act of 1940<\/strong>[1]<\/strong><\/a><\/sup>. The CDSCO is the national governing body for Obstetrical and Gynaecological Medical Devices. The Indian CDSCO is administered and\ngoverned by the Directorate General of Health Services or DGHS under the\nMinistry of Health & Family Welfare.  <\/p>\n\n\n\n

It performs similar duties to those of the National\nMedical Products Administration (NMPA) of China, the European Medicines Agency\n(EMA), the PMDA of Japan, the Food & Drug Administration (FDA) of the\nUnited States, the Medicines and Healthcare Products Regulatory Agency of the\nUnited Kingdom, and the European Medicines Agency (EMA) of the European Union. The Act and\nRules delegate numerous obligations for drug and cosmetic regulation in India\nto the Central and State Regulators. CDSCO is the Central Drug Control\nOrganization, which performs the tasks entrusted to the Central Government\nunder the Act. It also advises and coordinates the actions of state drug\ncontrol organisations. CDSCO and state regulators work together to provide\nlicences for certain specialised categories of essential drugs such as\nvaccines, blood and blood products, IV fluids, and sera. <\/p>\n\n\n\n

The status of a medical device\nwas enlarged beyond the 23 previously notified medical devices on April 1,\n2020, requiring that all medical devices be registered under The Drugs and\nCosmetics Act of 1940. Beginning October 1, 2022, all Class A and B medical\ndevices must be imported with an Import License. All remaining Class C and D\ndevices that have yet to be notified will require Import Licenses by October 1,\n2023. In this article, we will talk about CDSCO Registration for Obstetrical and Gynaecological Medical Devices.<\/p>\n\n\n\n

\n
\n

Page Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n